meto
Biomarker

HbA1c

Also known as Glycated Haemoglobin · Haemoglobin A1c

A blood marker of average glucose over the prior 3 months — the standard metric for diabetes screening and GH-axis protocol safety.

Definition

HbA1c reports the percentage of haemoglobin molecules with attached glucose, reflecting average blood glucose across the prior 10–12 weeks. Under 5.7% is normal; 5.7–6.4% is prediabetic; 6.5% and above meets the diabetic threshold. Meto requires HbA1c under 6.5% before starting P2, P4 or Tesamorelin; members on GLP-1 therapy typically see HbA1c drop 1–1.5 points over six months.

Reference Range: Under 5.7% normal; 5.7–6.4% prediabetic; 6.5%+ diabetic threshold

$149 panel.
A clinician reads it in 24 hours.

Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.